Steglatro (ertugliflozin)

ertugliflozin · Merck & Co

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Steglatro (ertugliflozin), covering 2025-05-06 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study [Phase 4]

See pricing